Probabilistic methods towards understanding complex human phenotypes using genomic and healthcare data

大规模生物数据集的出现挑战了现有的分析框架。大量的基因组分析数据赋予了将突变与特定组织中的基因表达变化联系起来的分子基础。EHR系统的广泛采用创造了丰富的表型数据，包括诊断代码，实验室测试和问卷调查。这些数据为开发新的机器学习方法提供了有希望的场所，以阐明引起表型差异和相互依赖的生物学机制。然而，由于缺乏可扩展的推理方法，现有的研究往往仅限于分析整个数据集的一小部分快照，无法解释数据的稀疏性、多模态性、纵向性、不规则采样性和非随机缺失性。 我们的长期愿景是开发新的机器学习方法，以人类可理解的方式破译基于遗传变异，细胞类型特异性，基因组调控元件，基因和途径功能及其与环境的相互作用的不同表型的病因。为了实现这一愿景，我们提出了四个短期目标。我们将开发： 1.贝叶斯模型解释异质数据分布的多模态，并通过潜在表型主题关联基因、组织、实验室结果、诊断代码来预测复合生物标志物， 2.生成模型，以插补相关的非随机缺失实验室结果和患者EHR中自我报告问卷的答案以及新患者不可访问组织样本中的基因表达， 3.基于纵向和不规则采样的门诊和住院病历， 4.分层贝叶斯网络，利用从基因组数据推断的序列突变的功能影响，并联合推断从驱动遗传变异、致病基因和途径到表型的定向路径。 我们提出的方法的关键创新在于，与现有的特设方法相比，我们同时学习我们提出的模型的所有组成部分（尽管它们很复杂），因此用互补信息协调不同的数据集。我们通过利用概率论和深度学习技术的可扩展变分推理算法来实现这一目标。 拟议的研究将推进贝叶斯学习，用于挖掘大量异质数据，并在医学中具有影响力的应用，包括复合生物标志物发现，基于估算的临床建议，预测健康轨迹，个性化风险预测，用于推断因果突变和疾病风险的深度可解释模型。总之，我们提出了一个步骤，通过有效的贝叶斯集成的大量数据，从而提高我们的理解级联事件从基因突变到广泛的表型谱的基因组和表型之间的差距差距。

The advent of massive biological datasets challenge existing analytic frameworks. Large genomic profiling data confer the molecular basis to link mutations to gene expression changes in specific tissues. The broad adoption of EHR systems creates rich phenotypic data including diagnostic code, lab tests, and questionnaires. These data provide promising venues for developing novel machine learning methods to elucidate the biological mechanisms that give rise to the phenotypic diversities and interdependence. However, due to the lack of scalable inference methods, existing research is often limited to analyzing only a small snapshot of the entire datasets and unable to account for the sparse, multimodal, longitudinal, irregularly sampled, and non-missing-at-random nature of the data. Our long-term vision is to develop novel machine learning methods to decipher, in a human-understandable manner, the etiology of diverse phenotypes based on genetic variants, cell-type specificities, genomic regulatory elements, gene and pathway functions, and their interactions with environments. In pursuing this vision, we propose four short-term objectives. We will develop: 1. Bayesian model to account for the multi-modality of the heterogeneous data distributions and predict composite biomarkers by associating genes, tissues, lab results, diagnosis codes via latent phenotypic topics, 2. generative model to impute correlated non-randomly missing lab results and answers to self-reported questionnaires in patients' EHR and gene expression in inaccessible tissue samples of new patients, 3. unsupervised model to infer latent trajectory of diverse patients' health states based on their longitudinal and irregularly sampled outpatient and inpatient medical records, 4. hierarchical Bayesian network that leverages the functional impacts of sequence mutations inferred from genomic data and jointly infer the directed paths from driver genetic variants, causal genes and pathways, and to phenotypes. The key innovation of our proposed methods is that, in contrast to the existing ad hoc methods, we learn all components of our proposed models simultaneously (despite their complexity) and therefore harmonize diverse datasets with complementary information. We achieve this by scalable variational inference algorithms that leverage probability theory and deep learning techniques. The proposed research will advance Bayesian learning for mining massive heterogenous data with impactful applications in medicine including composite biomarker discovery, imputation-based clinical recommendations, forecasting health trajectories, personalized risk predictions, deep interpretable models for inferring causal mutations and disease risks. Together, we present a step towards bridging the gap between the genome and the phenome by efficient Bayesian integrations of massive data, thereby improving our understanding of the cascading events from genetic mutations to a broad phenotypic spectrum.